Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001929354-23-000007

10% owner bought 25,000 shares at an average $2.77 ($69,365)

From the SEC's structured data for this filing

Trades in this filing

Caissa Capital Management ltd. · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-04 Purchase : show line 1 in the form +15,000 $2.79 $41,882 1,332,700 I
2023-05-05 Purchase : show line 2 in the form +5,000 $2.88 $14,375 1,337,700 I
2023-05-08 Purchase : show line 3 in the form +5,000 $2.62 $13,108 1,342,700 I
Open-market purchases · 25,000 sh · avg $2.77 · $69,365
Loading xslF345X04/primary_doc.xml…